MICHAEL WEISER
CIK 1221449 · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$728.6K
Companies
6
Total Filings
76
Lifetime Open-Market Net
-$7.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IOVA | Director | 141,116 | $4.70 | $663.2K | $68.0K | 12 | 2026-06-18 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 224,282 | $0.87 | $194.2K | -$98.0K | 21 | 2018-01-03 |
| Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Director | 450,178 | — | — | $13.8K | 16 | 2014-01-24 |
| EMIS | Director | 6,413 | $10.19 | $65.3K | $0 | 4 | 2009-05-19 |
| Talon Therapeutics, Inc. (HNAB) Delisted | Director | 140,417 | — | — | $8.4K | 3 | 2009-02-26 |
| TG THERAPEUTICS, INC. (MHA) Delisted | Director | 2,247,563 | — | — | $0 | 4 | 2007-08-02 |
Recent Filings · Page 2 of 8
76 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-07-19 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2018-03-19 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2018-01-03 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Mixed | +11,237 | -$24.9K | EDGAR |
| 2017-12-11 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Mixed | +7,675 | $0 | EDGAR |
| 2017-06-14 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Mixed | +1,700 | -$1 | EDGAR |
| 2017-05-24 | — | Grant (A) | — | $0 | |
| 2017-01-04 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Mixed | +7,873 | -$49.9K | EDGAR |
| 2016-05-26 | — | Grant (A) | — | $0 | |
| 2016-04-20 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Mixed | +4,249 | -$20.3K | EDGAR |
| 2016-01-05 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Mixed | +24,614 | -$17.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.